Literature DB >> 19268565

Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults.

N Fratzl-Zelman1, P Roschger, B M Misof, S Pfeffer, F H Glorieux, K Klaushofer, F Rauch.   

Abstract

Bone mineralization density distribution (BMDD) as assessed by quantitative backscattered electron imaging (qBEI) in iliac crest bone biopsies has become in the last years a powerful diagnostic tool to evaluate the effect of metabolic bone diseases and/or therapeutic interventions on the mineralization status of the bone material. However until now, normative reference data are only available for adults. The aim of the present study is to close this gap and establish normative data from children and compare them with reference BMDD data of adults. qBEI analyses were performed on bone samples from 54 individuals between 1.5 and 23 years without metabolic bone diseases, which were previously used as study population to establish normative histomorphometric standards. In the trabecular compartment, none of the BMDD parameters showed a significant correlation with age. The BMDD was shifted towards lower mineralization density (CaMean -5.6%, p<0.0001; CaPeak -5.6%, p<0.0001; CaLow +39.0% p<0.001; CaHigh -80.7%, p<0.001) and the inter-individual variation was higher compared to the adult population. The cortices appeared to be markedly less mineralized (CaMean -3.1%, p<0.0001) than cancellous bone due to higher amounts of low mineralized secondary bone. However, the cortical BMDD parameters showed a strong correlation (r=0.38 to 0.85, with p<0.001 to<0.0001) with cancellous BMDD parameters. In conclusion, this study provides evidence that BMDD parameters in growing healthy subjects are relatively constant and that these data can be used as normative references in pediatrics osteology. The larger inter-individual variability compared to adults is most likely related to alterations of the bone turnover rate during growth.

Entities:  

Mesh:

Year:  2009        PMID: 19268565     DOI: 10.1016/j.bone.2009.02.021

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  25 in total

Review 1.  Bone mineralization: from tissue to crystal in normal and pathological contexts.

Authors:  Y Bala; D Farlay; G Boivin
Journal:  Osteoporos Int       Date:  2012-12-11       Impact factor: 4.507

2.  Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.

Authors:  Roman Thaler; Antonio Maurizi; Paul Roschger; Ines Sturmlechner; Farzaneh Khani; Silvia Spitzer; Monika Rumpler; Jochen Zwerina; Heidrun Karlic; Amel Dudakovic; Klaus Klaushofer; Anna Teti; Nadia Rucci; Franz Varga; Andre J van Wijnen
Journal:  J Biol Chem       Date:  2016-01-12       Impact factor: 5.157

3.  COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.

Authors:  Katarina Lindahl; Aileen M Barnes; Nadja Fratzl-Zelman; Michael P Whyte; Theresa E Hefferan; Elena Makareeva; Marina Brusel; Michael J Yaszemski; Carl-Johan Rubin; Andreas Kindmark; Paul Roschger; Klaus Klaushofer; William H McAlister; Steven Mumm; Sergey Leikin; Efrat Kessler; Adele L Boskey; Osten Ljunggren; Joan C Marini
Journal:  Hum Mutat       Date:  2011-04-07       Impact factor: 4.878

4.  Precision of bone density and micro-architectural properties at the distal radius and tibia in children: an HR-pQCT study.

Authors:  C E Kawalilak; A T Bunyamin; K M Björkman; J D Johnston; S A Kontulainen
Journal:  Osteoporos Int       Date:  2017-09-18       Impact factor: 4.507

5.  Metaphyseal dysplasia with maxillary hypoplasia and brachydactyly is caused by a duplication in RUNX2.

Authors:  Pierre Moffatt; Mouna Ben Amor; Francis H Glorieux; Paul Roschger; Klaus Klaushofer; Jeremy A Schwartzentruber; Andrew D Paterson; Pingzhao Hu; Christian Marshall; Somayyeh Fahiminiya; Jacek Majewski; Chandree L Beaulieu; Kym M Boycott; Frank Rauch
Journal:  Am J Hum Genet       Date:  2013-01-03       Impact factor: 11.025

Review 6.  Multiscale contribution of bone tissue material property heterogeneity to trabecular bone mechanical behavior.

Authors:  Ashley A Lloyd; Zhen Xiang Wang; Eve Donnelly
Journal:  J Biomech Eng       Date:  2015-01       Impact factor: 2.097

7.  Relationship of bone mineralization density distribution (BMDD) in cortical and cancellous bone within the iliac crest of healthy premenopausal women.

Authors:  B M Misof; D W Dempster; Hua Zhou; P Roschger; N Fratzl-Zelman; P Fratzl; S J Silverberg; E Shane; A Cohen; E Stein; T L Nickolas; R R Recker; J Lappe; J P Bilezikian; K Klaushofer
Journal:  Calcif Tissue Int       Date:  2014-08-19       Impact factor: 4.333

8.  Phenotypic Spectrum in Osteogenesis Imperfecta Due to Mutations in TMEM38B: Unraveling a Complex Cellular Defect.

Authors:  Emma A Webb; Meena Balasubramanian; Nadja Fratzl-Zelman; Wayne A Cabral; Hannah Titheradge; Atif Alsaedi; Vrinda Saraff; Julie Vogt; Trevor Cole; Susan Stewart; Nicola J Crabtree; Brandi M Sargent; Sonja Gamsjaeger; Eleftherios P Paschalis; Paul Roschger; Klaus Klaushofer; Nick J Shaw; Joan C Marini; Wolfgang Högler
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

9.  Recessive osteogenesis imperfecta caused by missense mutations in SPARC.

Authors:  Roberto Mendoza-Londono; Somayyeh Fahiminiya; Jacek Majewski; Martine Tétreault; Javad Nadaf; Peter Kannu; Etienne Sochett; Andrew Howard; Jennifer Stimec; Lucie Dupuis; Paul Roschger; Klaus Klaushofer; Telma Palomo; Jean Ouellet; Hadil Al-Jallad; John S Mort; Pierre Moffatt; Sergei Boudko; Hans-Peter Bächinger; Frank Rauch
Journal:  Am J Hum Genet       Date:  2015-05-28       Impact factor: 11.025

10.  CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII.

Authors:  N Fratzl-Zelman; R Morello; B Lee; F Rauch; F H Glorieux; B M Misof; K Klaushofer; P Roschger
Journal:  Bone       Date:  2009-11-04       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.